McKinsey January 11, 2021
Aaron De Smet, Chris Gagnon, and Elizabeth Mygatt

The prospect of successful vaccines for COVID-19 has given business leaders everywhere hope that the pandemic may be finally nearing a turning point. And not a second too soon: the organizational adrenaline that helped many companies get things done quickly and well during the pandemic’s early days has, in many cases, been replaced by fatigue.

Yet even as leaders take action to reenergize their people and organizations, the most forward looking see a larger opportunity—the chance to build on pandemic-related accomplishments and reexamine (or even reimagine) the organization’s identity, how it works, and how it grows.

The pressure to change had been building for years. Well before the COVID-19 pandemic, senior executives routinely worried their...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Employer, Insurance, Medical Devices, Pharma / Biotech, Provider, Trends
GLP-1 drug coverage for obesity making inroads with large employers: Mercer
44% of large employers cover weight loss drugs for obesity: Mercer
Weight-loss Drug Coverage Rises Among Largest US Employers, Mercer Survey Finds
Most American adults qualify for semaglutide. Will employers cover the cost?
How AI Is Reshaping Industries And Creating Tomorrow’s Job Market

Share This Article